This is a non-core endpoint: only basic statistics are computed.
Chromomycosis and phaeomycotic abscess
AB1_CHROMOMYCOCIS
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
48 |
4. Check minimum number of eventsNone |
48 |
5. Include endpointsNone |
48 |
6. Filter based on genotype QC (FinnGen only) |
48 |
Control definitions (FinnGen only)
- Control exclude
- AB1_MYCOSES
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Chromomycosis and phaeomycotic abscess
based on the number of shared cases.
Similar with more cases:
- Mycoses
- Certain infectious and parasitic diseases
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 401 | 184 | 215 |
| Only index persons | 371 | 174 | 197 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 38.92 | 40.77 | 36.92 |
| Only index persons | 38.71 | 40.88 | 36.78 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 48 | 30 | 18 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 46.32 | 41.24 | 54.79 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(42870588) Differential panel, method unspecified - Blood
25
123
3.15
3.71
13.0
6.8
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
22
107
2.95
3.24
3.0
2.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
14
52
3.39
3.22
3.6
2.9
e6/l
0.8
2.6
—
6
34
(3030467) Casts [#/volume] in Urine by Automated count
21
106
2.74
2.82
3.2
2.7
e6/l
0.2
0.3
0.12
13
79
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
14
58
3.00
2.67
3.0
2.7
e6/l
0.7
0.9
—
6
39
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
10
36
3.25
2.37
8.1
5.7
u/l
230.1
243.7
—
10
36
(3002582) Erythrocytes [#/volume] in Urine
22
124
2.43
2.27
3.6
2.7
e6/l
18.0
27.4
0.46
14
98
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
7
19
4.12
2.24
10.0
6.2
—
—
—
0
0
(3002256) Pathology report gross observation
11
44
2.95
2.19
1.6
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
9
32
3.22
2.13
2.2
1.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
19
103
2.40
2.11
9.6
6.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
24
146
2.29
2.04
4.8
3.1
e6/l
116.5
35.1
0.52
15
103
(3000492) Spirometry study
8
28
3.22
1.96
1.6
1.4
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
6
17
3.88
1.90
11.7
8.9
mmol/l
24.5
25.3
—
6
17
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
10
41
2.82
1.90
1.5
2.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
20
116
2.24
1.87
4.9
3.0
u/l
25.1
31.5
1.27
20
109
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
0
48
0.00
1.82
0.0
7.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
15
78
2.34
1.79
6.1
4.2
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
16
88
2.23
1.67
7.6
3.8
%
96.4
90.2
0.62
16
88
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
10
44
2.61
1.66
1.3
1.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
9
38
2.68
1.56
1.2
1.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
24
159
2.02
1.54
8.6
7.1
mmol/l
1.2
1.2
0.59
24
145
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
5
16
3.36
1.47
1.2
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
16
93
2.08
1.44
2.3
2.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
26
181
1.95
1.42
13.7
9.1
e9/l
0.0
0.0
0.48
20
147
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
8
146
0.46
1.33
2.6
4.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
10
49
2.31
1.33
1.7
1.8
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
5
19
2.81
1.25
13.6
9.8
%
94.6
94.0
—
5
19
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
5
19
2.81
1.25
1.2
1.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
8
40
2.20
1.19
3.7
1.6
nmol/l
377.3
383.7
—
8
40
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
5
20
2.67
1.18
13.4
9.4
%
0.4
0.8
—
5
20
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
5
20
2.67
1.18
13.6
9.4
%
0.9
1.6
—
5
20
(3032080) INR in Blood by Coagulation assay
20
134
1.84
1.17
6.8
6.4
inr
1.3
1.2
—
6
49
(3000991) Gas panel - Venous blood
7
32
2.39
1.13
12.4
8.9
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
41
355
2.06
1.08
27.0
14.8
%
13.7
13.5
0.58
41
348
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
10
54
2.08
1.06
1.6
2.0
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
37
307
1.90
1.01
10.6
7.3
u/l
96.6
83.3
0.24
37
284
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
27
206
1.71
0.98
11.6
6.7
umol/l
11.0
10.8
0.06
27
190
(3024561) Albumin [Mass/volume] in Serum or Plasma
21
150
1.71
0.96
6.5
4.8
g/l
36.6
36.4
0.07
21
144
(3044640) Blood type and Crossmatch panel - Blood
18
123
1.74
0.96
5.9
2.1
—
—
—
0
0
(4035726)
6
29
2.22
0.93
1.7
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
8
44
1.98
0.91
1.3
1.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
24
0.00
0.82
0.0
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
24
0.00
0.82
0.0
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
24
0.00
0.82
0.0
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
24
0.00
0.82
0.0
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
24
0.00
0.82
0.0
1.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
19
140
1.59
0.74
3.8
3.2
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
5
26
2.03
0.73
2.6
12.7
mmol/l
25.0
24.8
—
5
26
(3041096) Erythrocytes [Presence] in Urine by Automated
6
104
0.52
0.72
2.7
3.0
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
5
27
1.95
0.70
2.8
5.1
mmol/l
1.3
1.2
—
5
22
(3017143) Hepatitis C virus Ab [Presence] in Serum
8
50
1.72
0.65
2.6
1.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
5
30
1.74
0.63
2.8
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
5
30
1.74
0.63
1.0
1.3
—
163.9
—
0
10
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
20
0.00
0.62
0.0
1.6
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
0
20
0.00
0.62
0.0
1.7
—
1.1
—
0
20
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
0
20
0.00
0.62
0.0
1.7
—
0.2
—
0
20
(40761511) CBC panel - Blood by Automated count
40
426
0.63
0.61
14.6
11.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
22
0.00
0.61
0.0
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
22
0.00
0.61
0.0
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
22
0.00
0.61
0.0
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
23
0.00
0.60
0.0
2.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
17
131
1.46
0.52
2.1
1.8
pmol/l
104.5
95.9
—
9
65
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
43
397
1.80
0.51
18.2
12.8
mg/l
23.8
23.3
0.03
32
299
(3019550) Sodium [Moles/volume] in Serum or Plasma
43
400
1.72
0.51
19.4
13.7
mmol/l
140.0
139.7
0.39
43
386
(3023103) Potassium [Moles/volume] in Serum or Plasma
43
400
1.72
0.51
19.8
13.7
mmol/l
3.9
3.9
0.00
43
387
(3011397) Hemoglobin [Presence] in Urine by Test strip
13
95
1.51
0.50
2.4
3.9
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
32
280
1.43
0.48
3.8
3.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
32
1.63
0.44
1.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
15
0.00
0.42
0.0
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.42
0.0
1.5
—
—
—
0
0
(3020891) Body temperature
0
16
0.00
0.42
0.0
5.3
—
—
—
0
0
(1002224) Polysomnography panel
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
0
17
0.00
0.41
0.0
1.7
—
136.0
—
0
5
(3002032) Base excess in Venous blood by calculation
5
35
1.48
0.40
4.0
8.5
mmol/l
-1.2
1.8
—
5
30
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
5
36
1.43
0.39
1.8
2.9
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
8
106
0.71
0.33
1.5
2.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
40
372
1.45
0.33
4.8
4.1
mmol/l
4.7
4.6
0.13
40
354
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
9
118
0.71
0.32
2.2
2.2
u/l
63.4
56.7
—
9
106
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
6
84
0.67
0.26
1.0
1.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
22
193
1.26
0.26
8.0
4.0
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
5
37
1.39
0.24
4.0
8.2
kpa
5.1
5.8
—
5
37
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
38
1.35
0.24
2.0
1.9
—
—
—
0
0
(3013512) EKG study
8
101
0.75
0.24
3.4
2.9
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
5
39
1.31
0.24
1.4
1.4
—
—
—
0
0
(3015736) pH of Urine
12
143
0.79
0.22
2.4
3.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
17
147
1.24
0.22
2.2
1.9
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
0
11
0.00
0.21
0.0
3.9
—
1.0
—
0
11
(4034850)
0
11
0.00
0.21
0.0
5.9
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
6
47
1.32
0.21
1.2
2.7
%
40.0
26.9
—
6
39
(3025130) Human papilloma virus identified in Specimen
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
6
48
1.29
0.21
1.3
2.6
g/l
1.9
2.4
—
6
42
(3023511) Choriogonadotropin [Units/volume] in Urine
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
6
52
1.18
0.20
1.3
2.6
umol/l
18.1
15.6
—
6
45
(3048689) Calprotectin [Mass/mass] in Stool
7
59
1.22
0.19
3.3
2.3
ug/g
41.3
83.8
—
7
44
(3013826) Glucose [Moles/volume] in Serum or Plasma
26
238
1.20
0.19
8.7
4.9
mmol/l
6.5
6.6
0.03
26
218
(3037467) Urinalysis macro (dipstick) panel - Urine
26
281
0.84
0.18
5.4
3.9
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
25
271
0.84
0.18
3.7
2.9
u/l
40.2
44.7
0.18
25
254
(3009542) Hematocrit [Volume Fraction] of Blood
39
374
1.23
0.15
24.4
13.1
%
39.0
40.1
0.34
34
291
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
5
44
1.15
0.10
1.4
2.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
6
56
1.08
0.09
1.2
1.6
nmol/l
741.7
1280.5
—
6
44
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
8
72
1.13
0.08
1.5
2.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
8
91
0.86
0.07
2.8
2.8
umol/l
297.1
10375.7
—
8
75
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
8
90
0.87
0.07
1.3
1.7
—
—
—
0
0
(3044889) 12 lead EKG panel
27
258
1.11
0.07
3.9
3.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
13
119
1.13
0.06
1.8
2.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
10
110
0.89
0.05
1.3
2.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
13
123
1.08
0.02
2.9
2.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
10
99
1.01
0.00
11.3
6.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
14
143
0.97
0.00
1.4
1.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
36
355
1.06
0.00
19.1
10.5
ml/min/173m2
85.1
86.9
0.17
31
282
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
6
63
0.95
0.00
1.2
1.5
pmol/l
456.8
554.0
—
6
54
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
9
96
0.92
0.00
6.1
4.7
ug/l
0.8
1.9
—
9
81
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
5.8
—
0
5
(3039162) Centromere protein B Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.3
—
4.2
—
0
9
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
43
422
1.18
0.00
16.2
10.2
u/l
25.7
25.3
0.06
43
407
(3022806) Fractional oxyhemoglobin in Capillary blood
0
6
0.00
0.00
0.0
1.5
—
94.1
—
0
6
(3004616) Nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
25.4
—
0
5
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
0
9
0.00
0.00
0.0
2.8
—
8.7
—
0
9
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
5.6
—
3205.1
—
0
7
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
1.8
—
2.0
—
0
5
(1761482) Bacteria [#/volume] in Urine by Culture
0
8
0.00
0.00
0.0
3.8
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
66.0
—
0
7
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
0
9
0.00
0.00
0.0
2.8
—
5.0
—
0
9
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
7.5
—
178.8
—
0
6
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint AB1_CHROMOMYCOCIS and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have AB1_CHROMOMYCOCIS.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: AB1_CHROMOMYCOCIS – Chromomycosis and phaeomycotic abscess
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data